Joseph Jankowski, PhD

Joseph Jankowski, PhD is a Professor in intellectual property commercialization and entrepreneurship in the Weatherhead School of Business and the Schools of Law and Medicine. Dr. Jankowski holds a PhD in chemistry from the State University of New York's College of Environmental Sciences, an MBA from CWRU's Weatherhead School of Management, and a dual BS in chemical and environmental engineering technologies from the University of Dayton.

Previously, Dr. Jankowski had been a commercialization officer in the Office of Innovations at the Cleveland Clinic Foundation (CCF). In that position, Dr. Jankowski helped to establish multinational sponsored research collaborations and to commercialize an array of intellectual property developed by CCF researchers. Prior to that, Dr. Jankowski held the position of technology analyst in the Environmental Technology Commercialization Center at the Battelle Memorial Institute and, before that, he was a research assistant with the SUNY Research Foundation.

Dr. Joseph Jankowski is the Associate Vice President for Technology Management. In this capacity, Dr. Jankowski leads the University's commercialization efforts that stem from the greater than $300 million of annual research activity taking place at the University and its affiliate institutions. Dr. Jankowski is very dedicated to CWRU's translational efforts and holds leadership roles on the Coulter-CWRU Translation and Innovation Partnership, the Ohio BRCP Center: Targeted Nanoparticles for Imaging and Therapeutics and the NorTech Tech Leaders Committee.

In addition to Dr. Jankowski's primary commercialization and translational activities, he is proud to represent CWRU through his participation in the CWRU Conflict of Interest Committee, the Ohio Technology Transfer Officers' Council, and the UHCMC Research Committee. Dr. Jankowski also serves the University through his active board representation in several CWRU spinoff companies, including Arteriocyte, Great Lakes Pharmaceuticals, Interventional Imaging, Inc and Neuros Medical.